Elon explicitly pushed back on today’s Business Insider “Macrohard stalled → pivot to Tesla” FUD. XAI minor staff churn, ...
It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.
UiPath (PATH) stock slides after Q4 FY26 results as Needham upgrades to Buy on ARR and free cash flow growth; AI ARR hits $200M.
Revenue of $481 million increased 14 percent year-over-year ARR of $1.853 billion increased 11 percent year-over-year GAAP ...
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced new agentic AI solutions for the healthcare industry for providers and payers at the ViVE 2026 ...
UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
OpenAI Group PBC today launched a new large language model that it says is more adept at automating work tasks than its earlier algorithms. GPT-5.4 is available in ChatGPT, the Codex programming tool ...
Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a decade, ...
Computing is part of everything we do. Computing drives innovation in engineering, business, entertainment, education, and the sciences—and it provides solutions to complex, challenging problems of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results